| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 65.292 | 103.525 | 136.122 | 132.707 | 138.081 | 158.024 | 147.295 |
| Total Income - EUR | - | - | - | 65.292 | 103.527 | 136.126 | 132.736 | 138.083 | 192.244 | 147.298 |
| Total Expenses - EUR | - | - | - | 18.569 | 40.572 | 49.469 | 47.627 | 56.839 | 79.473 | 66.971 |
| Gross Profit/Loss - EUR | - | - | - | 46.724 | 62.955 | 86.657 | 85.108 | 81.244 | 112.771 | 80.327 |
| Net Profit/Loss - EUR | - | - | - | 46.073 | 61.920 | 85.597 | 83.939 | 80.134 | 111.137 | 75.997 |
| Employees | - | - | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Dr. Bărbos Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 5.369 | 42.317 | 40.947 | 30.907 | 23.586 | 75.878 | 56.075 |
| Current Assets | - | - | - | 49.475 | 95.844 | 119.284 | 90.824 | 132.203 | 154.848 | 100.550 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 4.629 | 8.546 | 12.107 | 7.173 | 6.453 | 27.484 | 0 |
| Cash | - | - | - | 44.846 | 87.299 | 107.177 | 83.651 | 125.750 | 127.364 | 100.550 |
| Shareholders Funds | - | - | - | 51.157 | 112.086 | 133.538 | 86.829 | 126.676 | 228.736 | 82.318 |
| Social Capital | - | - | - | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | - | - | - | 3.687 | 26.075 | 26.693 | 34.902 | 29.112 | 1.990 | 74.307 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Bărbos Srl